ATYR aTYR PHARMA INCcompanySEC Filings & Insider Trading Activity 2026
Latest aTYR PHARMA INC (ATYR) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on March 5, 2026, a 10-Q quarterly report filed on November 6, 2025, an 8-K current report filed on March 5, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for aTYR PHARMA INC (ATYR) (SEC CIK 1339970), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 2.02: Results of Operations and Financial Condition
- • Full-year 2025 financial results announced March 5, 2026 — details in Exhibit 99.1
- • As a clinical-stage biopharma, key metrics to watch: cash runway, R&D spend, and any pipeline milestones cited in the release
Recent 8-K FilingsCurrent Reports
AI-powered analysis of aTYR PHARMA INC (ATYR) 8-K current reports disclosing material events.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Mar 5, 2026 | — | Analysis | — |
10-K | Mar 5, 2026 | Dec 31, 2025 | — | |
8-K | Dec 5, 2025 | — | — | |
10-Q | Nov 6, 2025 | Sep 30, 2025 | — | |
10-Q | Aug 7, 2025 | Jun 30, 2025 | — | |
10-Q | May 7, 2025 | Mar 31, 2025 | — | |
10-K | Mar 13, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 7, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 13, 2024 | Jun 30, 2024 | — | |
10-Q | May 2, 2024 | Mar 31, 2024 | — | |
10-K | Mar 14, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 9, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 9, 2023 | Jun 30, 2023 | — | |
10-Q | May 9, 2023 | Mar 31, 2023 | — | |
10-K | Mar 14, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 14, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 15, 2022 | Jun 30, 2022 | — | |
10-Q | May 10, 2022 | Mar 31, 2022 | — | |
10-K | Mar 15, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 12, 2021 | Sep 30, 2021 | — | |
10-Q | Aug 11, 2021 | Jun 30, 2021 | — | |
10-Q | May 14, 2021 | Mar 31, 2021 | — | |
10-K | Mar 24, 2021 | Dec 31, 2020 | — | |
10-Q | Nov 13, 2020 | Sep 30, 2020 | — | |
10-Q | Aug 13, 2020 | Jun 30, 2020 | — |
Frequently Asked Questions
What are the latest ATYR SEC filings in 2026?
aTYR PHARMA INC (ATYR) has filed a 10-K annual report on March 5, 2026, a 10-Q quarterly report on November 6, 2025, an 8-K current report on March 5, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did ATYR file its most recent 10-K annual report?
aTYR PHARMA INC (ATYR) filed its most recent 10-K annual report on March 5, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view ATYR 10-Q quarterly reports?
aTYR PHARMA INC (ATYR)'s most recent 10-Q quarterly report was filed on November 6, 2025. SignalX displays every ATYR 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has ATYR filed recently?
aTYR PHARMA INC (ATYR)'s most recent 8-K was filed on March 5, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find ATYR insider trading activity (Form 4)?
SignalX aggregates every ATYR Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does ATYR file with the SEC?
aTYR PHARMA INC (ATYR) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new ATYR filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for aTYR PHARMA INC (ATYR).
What is ATYR's SEC CIK number?
aTYR PHARMA INC (ATYR)'s SEC CIK (Central Index Key) number is 1339970. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1339970 to look up all ATYR filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find ATYR return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from aTYR PHARMA INC (ATYR) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of aTYR PHARMA INC SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 46+ filings.